Available for Download
STANDARDS FOR THE SAFER USE OF EPMA SYSTEMS FOR USE IN SACT SERVICES
Published February 2022
The main purpose of this document is to improve safety to patients and maintain consistency throughout the UK. The document was first published by the BOPA in 2015 and updated in 2019. The current version has been extensively reviewed by representatives of the whole oncology workforce in the UK to reflect the multidisciplinary use of this document.
MEDICATION-RELATED OSTEONECROSIS OF THE JAW: GUIDANCE FOR THE ONCOLOGY MULTI-DISCIPLINARY TEAM
This guidance has been produced by a multi-disciplinary working party on behalf of the UK Chemotherapy Board and endorsed by the Clinical Standards Committee of the Faculty of Dental Surgery of the Royal College of Surgeons of England. It focuses on all aspects of MRONJ in relation to oncology patients.
MORBIDITY AND MORTALITY WITHIN 30 DAYS OF SACT - REVIEW OF CURRENT PRACTICE - STANDARDISED REVIEW PROCESS
Good to Know
The UK Chemotherapy Board recognised the many current examples of good practice but noted an inconsistency of approach between centres which may limit sharing of learning. It has summarised the key details of the processes currently used and developed a proposed template for an operational policy and pro forma.